Chinese medicines are entered " Vie for imitative era " Hide the safe secret worry behind the low price

Chinese medicines are entered " Vie for imitative era " Hide the safe secret worry behind the low price
Original innovative medicine one " The marathon " Its battle The trade environment of Chinese medicine can be here " Gold ten year " In facilitate it is great is it new dream of that medicine? In " not bad money " China,it is new research and develop medicine not gaining yet the favors of investor. "There is only pharmacy in China, do not have new medicine. " Protect promise science and technology (Beijing) Vice President of limited company Deng TianJing tells " Liaowang " Newsweek. What Deng TianJing belonged to is that a biological medical services charters enterprises outside. This kind serves transnational medical enterprise, earns " Work as a temporary labourer and take " Enterprise getting fast more growing in recent years,enjoy its outstanding one by respect of industries international even already. In the face of success of this kind of commerce, a considerable amount of professionals do not rather consider worth doing - -Their ultimate dream, lock and develop China " heavy scale bomb " tightly New medicine of grade. On May 25, Pan GuangCheng, Deputy Chairman of China Association of Chemistry Pharmaceutical Industry is in " international medical industries and medicine forums " On claim from this year last " the ten year such as gold " China pharmacy . Then, Chinese trade of medicine environment can in " the 10 years such as gold " this In dream facilitated on its on medicines new when it is great? " temporary labourer " Protect promise with whom TianJing Deng belong to Company the same, many enterprise put down passion that new medicine researches and develops, the ones that are absorbed in doing the transnational medical enterprises service and wrapped up outside " Temporary labourer " --Suppose a new medicine needs to research and develop the time, input of research and development of 1 billion dollars in 8 on average, this game does not have a lot of enterprises that can pay the price for it. Protect promise company and utilize transnational medical enterprises, especially bio-pharmaceuticals enterprises, have an optimistic view of the intersection of China and natural the intersection of medicine and resource and the intersection of talent and chance of advantage, undertake earlier stage new the intersection of medicine and work that medicine researches and develops etc. formate, not clinical, its. These enterprises are usually said CRO. In Zhangjiang Hi-tech Park of Shanghai, 33 CROs have mainly served transnational medicine enterprise already. But in serving the export share composition wrapped up outside in last year Beijing, biological medicine increasing degree was up to 149%. Deputy Director of Chinese Academy of Medical Sciences institute of materia medica Du GuanHua says, it is the course of accumulating independent innovation ability that the medical enterprises of our country undertake to research and develop wrapping up outside, but its environmental pollution, resource that cause are consumed and can't be neglected. The more serious one is, according to the professional etiquette, because CRO is exposed to the transnational medical enterprise's technical data, can't research and develop new medicine by oneself. Deng TianJing says, though they have known new medicine research and develop technology, since the company orientates as serving to wrap up outside, can't violate the professional etiquette and research and develop new medicine by oneself. Otherwise " will make the intersection of pharmacy and the intersection of enterprise and right and cooperative the intersection of production and worry of us, worry the intersection of oneself and security of intellectual property right. " "This is a double-edged sword. " Zhangjiang general manager of base Development Co., Ltd. Wang LanZhong of biological medicine of Shanghai says, making CRO for transnational medical enterprises brings the business opportunity to drugmaker of our country, but let some enterprises lose and research and develop the motive force of new medicine by oneself to a certain extent too. The ones that grind medicines and model medicine meanwhile play chess originally, transnational medical enterprises are accelerating the overall arrangement, fight for the cakes of the medical market of China. Du GuanHua says, influenced by financial crisis, the transnational medical giant of the top ten of world ranking researches and develops the cost in order to reduce medicine, seek the new medicine and find the route, set up and research and develop the organization in our country one after another, research and develop the field to expand from chemical medicine to biological medicine gradually, and regard as the first batch of markets that new medicine is listed here. "Transnational medical enterprises realize that compete with us at the gate of our home, utilize the advantage of technology, form medicine of our nation the new round ofly and assault. " A popular view is, patent medicine implemented at present, grinding medicines and models medicines and part in the pricing mechanism originally, helping transnational medical enterprises to earn a large sum of profits in China, they researched and developed fund input immediately, this widens the native medicine enterprise and disparity of the international giant. The pharmacy general manager of Co., Ltd. Liu HongXing of Taide in Beijing says, imported medicine prices and enjoys ultra national treatment to have a long history in our country, once the systems of domestic medicine, joint-venture medicine, imported medicine distinguished, carried on the reform to this later, carry out medicine of patent, grind medicines and models medicines and price respectively originally, and does not participate in the bid of medicines on the same aspect. Grind medicines while being what is called, in our country, mainly refer to imported medicine of protection period of patent. This kind of medicine is thought quality to account for excellently therefore enjoys the policy of pricing alone etc. to protect. The pharmacy group's Chairman Cai DongChen in Shijiazhuang thinks, medicine of patent, grinding medicines because of being protected by the policy originally, the range on a price reduction is smaller than imitation medicine in all previous reduction. Sodium is as the example with the parenteral very beginning spore's Qusong, what a foreign large-scale enterprise produced grinds medicines to price and up to more than 90 yuan originally, but domestic modelling medicines only has four or five yuan, price of the two is lack of 20 times. "It is right to protect the fixed price to patent medicine of foreign countries, but grinding medicines to protect originally of protection period of patent to already passing, such special treatment is unreasonable. " In fact, model medicines with grinding the playing chess and already beginning of medicine originally. The view thinks, single pricing,etc. carrying out in grinding medicines originally is protected, it is in fact a kind of compensation - -Because China leads to the fact to the lack of protection of intellectual property right of new medicine imitation medicine prevails. Learn to be counted according to China hygiene economy, more than 97% of the domestic medicines, in order to model medicines, foreign capitals and medical enterprise of joint-venture have basically occupied medicine of patent, ground the market of medicine originally. The hot topic in industrial circle, national Vice chief of development and reform committee Pricing Department Liu shake in the 2009 of autumn in " China's medical system reform - -The opportunity and challenge " Say, will change the disparity at the price narrowed and ground medicines and modelled medicine of the single pricing policy originally in the future on the international summit forum, the ones that are listed grind medicine originally but wanted and models the price of medicine and connect on the whole too newly; The ones that have already been listed have modelled medicines, so long as accord with the state policies, or relevant supervision departments or authoritative organizations prove that have the advantage of being obvious, can be with the appropriate difference of the uniform price. "In fact a high-quality modelling medicines needs enterprises to invest very great research and development strength too, but it should be a little easier to stand on the giant's shoulder, need encouraging needing to control. " Biotechnology and new medical industry of Beijing promote a pool engineering of Deputy Director in the centre to say. According to the introduction of a pool engineering, it already accounts for more than 40% of the market of global medicines at present to model the market of medicine, in the following 3 years, there will be medicines up to 137 billion dollars of annual sales amount in the world to lose patent protection. This means, a piece of medicines " vies for imitative era " Will come soon. " only the low price is lifted " " vie for imitative era " The one that bring is only the enormous market opportunity? The person in charge of enterprise of a pharmacy of Henan tells our publication, regard 60 films each bottles of compound root of red-rooted salvia slice and 10g * 20 bags of blue root particles of board as the example, its cost of material is 1.41 yuan and 4.2 yuan separately, however, the biding price of the market is 0.7 yuan and 2 yuan. How was low price medicine produced out? The health reason group's Chairman Xiao Wei in Jiangsu says, the country has stipulated the supreme retail price of medicines, but a lot of provinces? Deceive, shine brown to smell of fish And then lead Zhang and imitate �� Assuare �� teases and leads �� Divide oblique Zou benefit covered with clouds and chew the clump and lower the spit of fland? Xiao Wei points out, this is extremely apt to produce two serious consequences: First, because the price is too low, enterprises are unable to supply, " win a bid and die " ,Especially basic medicine, one's own prices and gross profit rates have been already very low, constantly reduction will making enterprises sustain losses in business and unable to supply, lead to the fact some basic medicines disappear on the market, patients do not have medicine that can be used; Second, some enterprises make a desperate move in order to survive, the method of taking the minimum to throw the material, scamp work, adulterate etc. reduces the entreprise cost, cause the serious medicines quality potential safety hazard. "These is leading enterprises and regarding lowering costs as the only goal virtually, increase person's hidden danger with safe administration. " Obviously, for excessively getting deeply stuck in the medical trade of China of modelling, low price malignant competition mire, " vie for imitative era " May also bury the safe secret worry of medicines. The medical business administration association of China will longer than MingDe and say, medicines are a kind of goods, should accord with law on the market, the cost can not be reduced limitlessly. In " only act that the low price is " Bid lay," getting more imitation excessively" The question brought is a malignant competition. The market of Shanghai has already had 32 basic medicine varieties " Disappear " ,Shanghai calls for bid and does having to send out to the basic medicine manufacturing enterprise " Submit a tender in invitation " Call. "An obvious result is, the ones that give up being produced are mostly some large and medium-sized enterprises. " Yu MingDe says. And large and medium-sized enterprise, is usually thought even more in order to pay attention to the quality control of medicines. Li DaPeng, academician of Chinese Academy of Engineering, says, the price of medicines is timid and high, circulating in links and the hospital mainly, medicines in the national basic medicine catalogue are the meagre profit, if fall into the price war, violate medicines and call for bid " Quality has priority, the price is reasonable " Original intention,initiate very easily the ones great quality safety crisis. A citizen in Beijing of bottleneck of innovative traditional Chinese medicine tells reporters, he is used to using traditional Chinese medicine, but there are too many traditional Chinese medicine varieties, the quality difference is too big, it is likewise the blue root particle of the board, some's price per box is 9 yuan, but some only sell at 1 yuan, the price is lack of 8 times, this is very abnormal. The reporter knows, will be effective in cure that the effective composition content must become certain in traditional Chinese medicine, but the traditional Chinese medicine varieties of some income " Chinese pharmacopoeias " are accident content, this is apt to cause medicines low-levelly to model, can't control product quality effectively, cause some traditional Chinese medicine products to give a great discount on curative effect, influence curing the sickness to save the patient seriously. As if the ڌ will of eldest grandson of group's director of west pharmacy says, because of historical reasons, the traditional Chinese medicine quality criteria is not high, cause the low-level repeated construction of traditional Chinese medicine trade directly, it is serious to compete with quality, a lot of, break up, messy, and then lead to the fact the bad, clinical curative effect of the quality controllability is unstable. "This industry which concerned body health and life security has already reached the edge of the crisis, demand urgently to improve the quality criteria. " It is reported, China has nearly 2000 enterprises of traditional Chinese medicine at present, trade concentration degree is not high, there are very few more than 1 billion output value enterprises. Wu, academician of Chinese Academy of Engineering, advise so as to mountain range, the country should make great efforts to encourage medical enterprises to enlarge and strengthen, improve innovation ability and product quality. Should set up many index content to determine in the traditional Chinese medicine quality criteria, define more it is determined and controlled that medicines are realized by and material composition the content to many kinds of index compositions, change and produce the quality criteria " It is not quantitative to determine the nature " Orthodox practice, inferior medicine have no place to hide. Li ZhenJiang, Chairman of medicine company of the martial prowess says, the autonomous innovation of the medical trade needs a large amount of input, and the risk is great, the enterprises without capability are difficult to implement. But if the market achievement is captured by some small enterprises, that is very unreasonable. "Should depend on the expert's strength, make sure medicines high quality and favourable price, science price on the basis of surveying and studying, guarantee the medicine manufacturing enterprise is lucrative, but this profit must be controlled in the reasonable range. " Famous cardiologist Ge JunBo thinks, research and development of a piece of medicines, cost of the manufacture process, the expert in the relevant field has an account in the heart more or less, while setting up medicines to price in expert's storehouse, expert's random sampling system of adopting medicines and pricing, prevent it from being blinded by the lust of gain. Scientific and technological office Deputy Bureau Director Xiong Ping of high and new technology industrial development zone in Chengdu proposes, the national related departments should strengthen control, is examining and approving links and preventing a kind of medicines from being modelled too many, too excessive. In addition, can utilize lever of price too, for example, are pricing links are guaranteeing " the first imitative medicine " that enterprises work hard to research and developing Sell the high price, " imitate medicines two times " , " three imitates medicines " And 10% of modelling the price of medicine and decreasing progressively sequentially, have no space of profit to excessively model medicines to let. In " mend medicine with medicine " System under,is it low to break through model at end,nearly last lines of insoluble topic - -The native medicine enterprise needs depending on " The price war " Strive for market share, its little small profits obtained are moist and unable to support huge new medicine to research and develop, there is not original innovative medicine, it is difficult to enjoy dignity and reasonable profit space. Liu ZhenQiu shows on the aforesaid forum, the price reform of medicines will reduce the overall level of raising the price of the links of circulating appropriately, the raising the price rate is controlled actually to the links of circulating. The proportion that 15% of price markup that medical organization medicines implement at present are sold will be reduced progressively, explore that tries the policy of raising the price of the difference. The area that pursues pilot reform of public hospital, will explore that cancels the addition of medicines, study and set up medicine thing service charge system. Whether these imaginations could improve the system environment of China's medical industry, merit attention. After all, if liken researching and developing original innovative medicine to of marathon, the existing system is undoubtedly the enormous test of athlete's endurance. Gentle / the intersection of " the Liaowang " and Zhang Tao of Newsweek reporter straight flat Sun Tie circle in the air

|